156 related articles for article (PubMed ID: 17591353)
1. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones.
Vesely DL; Eichelbaum EJ; Sun Y; Alli AA; Vesely BA; Luther SL; Gower WR
In Vivo; 2007; 21(3):445-51. PubMed ID: 17591353
[TBL] [Abstract][Full Text] [Related]
2. Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice.
Vesely DL; Vesely BA; Eichelbaum EJ; Sun Y; Alli AA; Gower WR
In Vivo; 2007; 21(6):973-8. PubMed ID: 18210743
[TBL] [Abstract][Full Text] [Related]
3. Novel therapeutic approach for cancer using four cardiovascular hormones.
Vesely DL; Clark LC; Garces AH; McAfee QW; Soto J; Gower WR
Eur J Clin Invest; 2004 Oct; 34(10):674-82. PubMed ID: 15473892
[TBL] [Abstract][Full Text] [Related]
4. Twice-weekly intravenous treatment of pancreatic cancer with atrial natriuretic peptide and vessel dilator.
Lenz A; Sun Y; Eichelbaum EJ; Skelton WP; Pi G; Vesely DL
In Vivo; 2010; 24(2):125-9. PubMed ID: 20363982
[TBL] [Abstract][Full Text] [Related]
5. Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.
Lenz A; Sun Y; Eichelbaum EJ; Skelton WP; Pi G; Vesely DL
Eur J Clin Invest; 2010 Mar; 40(3):242-9. PubMed ID: 20415699
[TBL] [Abstract][Full Text] [Related]
6. Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice.
Eichelbaum EJ; Sun Y; Alli AA; Gower WR; Vesely DL
Eur J Clin Invest; 2008 Aug; 38(8):562-70. PubMed ID: 18717826
[TBL] [Abstract][Full Text] [Related]
7. Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.
Vesely BA; Alli AA; Song SJ; Gower WR; Sanchez-Ramos J; Vesely DL
Eur J Clin Invest; 2005 Nov; 35(11):700-10. PubMed ID: 16269020
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical localization of atrial natriuretic peptide, vessel dilator, long-acting natriuretic peptide, and kaliuretic peptide in human pancreatic adenocarcinomas.
Saba SR; Garces AH; Clark LC; Soto J; Gower WR; Vesely DL
J Histochem Cytochem; 2005 Aug; 53(8):989-95. PubMed ID: 15879575
[TBL] [Abstract][Full Text] [Related]
9. Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cells.
Skelton WP; Pi G; Lenz A; Sun Y; Vesely DL
Eur J Clin Invest; 2010 Aug; 40(8):706-12. PubMed ID: 20546014
[TBL] [Abstract][Full Text] [Related]
10. Central role of β-catenin in anticancer effects of cardiac hormones.
Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2013 Jun; 33(6):2409-14. PubMed ID: 23749889
[TBL] [Abstract][Full Text] [Related]
11. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
Vesely DL
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of AKT in human pancreatic, renal and colorectal cancer cells by four cardiac hormones.
Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2013 Mar; 33(3):785-90. PubMed ID: 23482745
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptides: anticancer agents.
Vesely DL
J Investig Med; 2005 Nov; 53(7):360-5. PubMed ID: 16297362
[TBL] [Abstract][Full Text] [Related]
14. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin.
Vesely DL; Perez-Lamboy GI; Schocken DD
Metabolism; 2000 Dec; 49(12):1592-7. PubMed ID: 11145122
[TBL] [Abstract][Full Text] [Related]
15. Four peptide hormones decrease the number of human breast adenocarcinoma cells.
Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Solivan SM; Gower WR; Vesely DL
Eur J Clin Invest; 2005 Jan; 35(1):60-9. PubMed ID: 15638821
[TBL] [Abstract][Full Text] [Related]
16. Five cardiac hormones decrease the number of human small-cell lung cancer cells.
Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Alli AA; Solivan SM; Gower WR; Vesely DL
Eur J Clin Invest; 2005 Jun; 35(6):388-98. PubMed ID: 15948900
[TBL] [Abstract][Full Text] [Related]
17. Four cardiac hormones cause death of human cancer cells but not of healthy cells.
Skelton WP; Pi GE; Vesely DL
Anticancer Res; 2011 Feb; 31(2):395-402. PubMed ID: 21378317
[TBL] [Abstract][Full Text] [Related]
18. Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2007; 27(3B):1387-92. PubMed ID: 17595752
[TBL] [Abstract][Full Text] [Related]
19. Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Skelton WP; Lenz A; Wang H; Vesely DL
Anticancer Res; 2009 Apr; 29(4):971-5. PubMed ID: 19414334
[TBL] [Abstract][Full Text] [Related]
20. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure.
Vesely DL; Perez-Lamboy GI; Schocken DD
J Card Fail; 2001 Mar; 7(1):55-63. PubMed ID: 11264551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
